Back to results
US 5,962,300 AGranted
Human kallikrein
AssigneeIncyte Pharmaceuticals, Inc.
InventorsJennifer L. Hillman, Preeti Lal
Life of this patent
Estimating the term…
Abstract
The present invention provides a human tumor suppressor (HKALL) and polynucleotides which identify and encode HKALL. The invention also provides expression vectors and host cells, agonists, antibodies, or antagonists. The invention provides methods for treating diseases associated with expression of HKALL.
Claims9
An isolated and purified polynucleotide encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:1.
An isolated and purified polynucleotide comprising SEQ ID NO:2.
Dependencies are inferred from the claim text.